Ukr.Biochem.J. 2023; Volume 95, Issue 6, Nov-Dec, pp. 64-72
doi: https://doi.org/10.15407/ubj95.06.064
AUT-M enterosorbent stabilizes glutathione system in vincristine-treated rats with dimethylhydrazine-induced colon cancer
O. I. Kachur*, L. S. Fira, P. H. Lykhatskyі,
I. R. Bekus, M. V. Kyryliv
I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine;
*e-mail: oksana.kachur2012@gmail.com
Received: 15 August 2023; Revised: 17 October 2023;
Accepted: 01 December 2023; Available on-line: 18 December 2023
Colorectal cancer is one of the leading causes of mortality in the world. The search for new methods of therapy for this disease that could correct the state of oxidative stress during the development of neoplasms is up to date. The aim of this work was to study the level of reduced glutathione and the activity of glutathione-dependent enzymes in the development of 1,2 dimethylhydrazine-induced colon cancer in rats while treated with vincristine and the use of enterosorbent. To induce carcinogenesis, dimethylhydrazine was administered to male rats subcutaneously for 30 weeks at a dose of 7.2 mg/kg of body weight. The rats with induced colon cancer received entorosorbent per os at a dose of 0.2 g per 100 g of body weight daily for 21 days. After detoxification therapy, the rats were administered cytostatic vincristine daily at a dose of 0.23 mg/kg for 14 days. A decrease in the content of reduced glutathione, the activity of glutathione reductase and glutathione peroxidase in the blood and liver tissue of rats with colorectal cancer was established. The use of enterosorbent AUT-M was shown to be effective in stabilizing the indicators of the glutathione system in rats with induced colon cancer. Cytostatic vincristine did not significantly affect the change of the studied indicators, confirming the effectiveness of previous sorption measures.
Keywords: blood, colorectal cancer, entorosorbent, glutathione, glutathione peroxidase, glutathione reductase, liver, vincristine
References:
- Marushchak M, Maksiv K, Krynytska I, Stechyshyn I. Glutathione antioxidant system of lymphocytes in the blood of patients in a setting of concomitant chronic obstructive pulmonary disease and arterial hypertension. Pol Merkur Lekarski. 2019;47(281):177-182. PubMed
- Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A. Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev. 2017:2017:8416763. PubMed, PubMedCentral, CrossRef
- Posokhova K, Stechyshyn I, Krynytska I, Marushchak M, Birchenko I, Klishch I. Comparative study of the effect of various forms of quercetin on experimental diabetes. Rom J Diabetes Nutr Metab Dis. 2018;25(4):383–388. CrossRef
- Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217(7):2291-2298. PubMed, PubMedCentral, CrossRef
- Jiao Y, Wang Y, Guo S, Wang G. Glutathione peroxidases as oncotargets. Oncotarget. 2017;8(45):80093-80102. PubMed, PubMedCentral, CrossRef
- Kennedy L, Sandhu JK, Harper ME, Cuperlovic-Culf M. Role of Glutathione in Cancer: From Mechanisms to Therapies. Biomolecules. 2020;10(10):1429. PubMed, PubMedCentral, CrossRef
- Minich DM, Brown BI. A Review of Dietary (Phyto)Nutrients for Glutathione Support. Nutrients. 2019;11(9):2073. PubMed, PubMedCentral, CrossRef
- Shevchuk O, Snezhkova E, Sarnatskaya V, Mikhailenko V, Glavin A, Makovetska L, Bardakhivska K, Birchenko I, Kozynchenko O, Nikolaev V. Effect of Primary and Secondary Beads of Carbon Enterosorbent on Haematological Parameters and Oxidative Stress Development Caused by Melphalan in Rats. Medicina (Kaunas). 2019 Sep 2;55(9):557. PubMed, PubMedCentral, CrossRef
- Sakhno LA, Babenko LP, Lazarenko LM, Korotych VG, Sarnatskaya VV, Snezhkova EA, Spivak MY, Nikolaev VG. Efficacy of dispersed fibrous carbon sorbent in treatment of malignant fungating wounds. Exp Oncol. 2021;43(4):359-364. PubMed, CrossRef
- Sakhno LA, Sarnatskaya VV, Yushko LA, Snezhkova EA, Bardakhivskaya KI, Shevchuk OO, Sidorenko AS, Nikolaev VG. Adsorptive therapy as a modificator for tumor-host interaction. Exp Oncol. 2019;41(3):254-257. PubMed, CrossRef
- Sarnatskaya V, Shlapa Y, Lykhova A, Brieieva O, Prokopenko I, Sidorenko A, Solopan S, Kolesnik D, Belous A, Nikolaev V. Structure and biological activity of particles produced from highly activated carbon adsorbent. Heliyon. 2022;8(3):e09163. PubMed, PubMedCentral, CrossRef
- Soroka Y, Andriichuk I, Lykhatskyi P, Fira L, Lisnychuk N. Violation of the prooxidant-antioxidant balance in the spleen tissue under experimental carcinogenesis. Georgian Med News. 2020;(308):123-128. (In Russian). PubMed
- Nair A, Morsy MA, Jacob S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development. Drug Dev Res. 2018;79(8):373-382. PubMed, CrossRef
- Vlizlo VV, Fedoruk RS. Laboratory methods of investigation in biology, stock- breeding and veterinary. Reference book. Spolom, Lviv: 2012. 764.
- Bardelčíková A, Šoltys J, Mojžiš J. Oxidative Stress, Inflammation and Colorectal Cancer: An Overview. Antioxidants (Basel). 2023;12(4):901. PubMed, PubMedCentral, CrossRef
- Gerashchenko BI, Sarnatskaya VV, Bardakhivska KI, Sydorenko OS, Kolesnik DL, Klymchuk DO. Myeloprotection with activated carbon in doxorubicin-treated rats. Heliyon. 2023;9(7):e18414. PubMed, PubMedCentral, CrossRef
- Gunasekaran S, Venkatachalam K, Namasivayam N. Anti-inflammatory and anticancer effects of p-methoxycinnamic acid, an active phenylpropanoid, against 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Mol Cell Biochem. 2019;451(1-2):117-129. PubMed, CrossRef
- Kachur О, Fira L, Lykhatskyy P, Fira D, Stechyshyn I. The state of pro-and antioxidant systems in rats with DMH-induced colon carcinogenesis on the background of extracorporeal detoxification. Pharmacia. 2021;68:941. CrossRef
- Koeberle SC, Gollowitzer A, Laoukili J, Kranenburg O, Werz O, Koeberle A, Kipp AP. Distinct and overlapping functions of glutathione peroxidases 1 and 2 in limiting NF-κB-driven inflammation through redox-active mechanisms. Redox Biol. 2020.28:101388. PubMed, PubMedCentral, CrossRef
- Kachur O, Fira L, Lykhatskyі P, Fira D, Garlitska N. Evaluation of membrane-destructive processes in rats with induced carcinogenesis of the colon using the cytostatic vincristine. Rocz Panstw Zakl Hig. 2022;73(2):215-220. PubMed, CrossRef
- Hassan AK, El-Kalaawy AM, Abd El-Twab SM, Alblihed MA, Ahmed OM. Hesperetin and Capecitabine Abate 1,2 Dimethylhydrazine-Induced Colon Carcinogenesis in Wistar Rats via Suppressing Oxidative Stress and Enhancing Antioxidant, Anti-Inflammatory and Apoptotic Actions. Life (Basel). 2023;13(4):984. PubMed, PubMedCentral, CrossRef
- Mandal P. Potential biomarkers associated with oxidative stress for risk assessment of colorectal cancer. Naunyn Schmiedebergs Arch Pharmacol. 2017;390(6):557-565. PubMed, CrossRef
- Morsy HM, Ahmed OM , Zoheir KMA, Abdel-Moneim A. The anticarcinogenic effect of eugenol on lung cancer induced by diethylnitrosamine/2-acetylaminofluorene in Wistar rats: insight on the mechanisms of action. Apoptosis. 2023;28(7-8):1184-1197. PubMed, PubMedCentral, CrossRef
- Mys LA, Strutynska NA, Goshovska YV, Sagach VF. Stimulation of the endogenous hydrogen sulfide synthesis suppresses oxidative-nitrosative stress and restores endothelial-dependent vasorelaxation in old rats. Can J Physiol Pharmacol. 2020;98(5):275-281. PubMed, CrossRef
- Škubník J, Svobodová Pavlíčková V, Ruml T, Rimpelová S. Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics. Biology (Basel). 2021;10(9):849. PubMed, PubMedCentral, CrossRef
- Madsen ML, Due H, Ejskjer N, Jensen P, Madsen J, Dybker K. Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Cancer Chemother Pharmacol. 2019;84(3):471-485. PubMed, PubMedCentral, CrossRef
- Saeedan AS, Rastogi S, Ansari MN. Roflumilast counteracts DMH-induced preneoplastic colon damage in albino Wistar rats. Hum Exp Toxicol. 2020;39(11):1545-1555. PubMed, CrossRef
This work is licensed under a Creative Commons Attribution 4.0 International License.







